Han J - Search Results

1

A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.

Matthews DR, Paldánius PM, Stumvoll M, Han J, Bader G, Chiang Y, Proot P, Del Prato S. Matthews DR, et al. Among authors: han j. Diabetes Obes Metab. 2019 Oct;21(10):2240-2247. doi: 10.1111/dom.13800. Epub 2019 Jun 30. Diabetes Obes Metab. 2019. PMID: 31144427 Free PMC article. Clinical Trial.

2

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.

Leiter LA, Raal FJ, Schwartz GG, Koenig W, Ray KK, Landmesser U, Han J, Conde LG, Wright RS. Leiter LA, et al. Among authors: han j. Diabetes Obes Metab. 2024 Aug;26(8):3223-3237. doi: 10.1111/dom.15650. Epub 2024 May 17. Diabetes Obes Metab. 2024. PMID: 38757725 Clinical Trial.

3

BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension.

Elger CE, Hong SB, Brandt C, Mancione L, Han J, Strohmaier C. Elger CE, et al. Among authors: han j. Epilepsia. 2017 Jul;58(7):1217-1226. doi: 10.1111/epi.13771. Epub 2017 May 13. Epilepsia. 2017. PMID: 28500678 Clinical Trial.

4

Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.

Taher AT, Origa R, Perrotta S, Kouraklis A, Belhoul K, Huang V, Han J, Bruederle A, Bobbili P, Duh MS, Porter JB. Taher AT, et al. Among authors: han j. Am J Hematol. 2019 Apr;94(4):E96-E99. doi: 10.1002/ajh.25408. Epub 2019 Jan 31. Am J Hematol. 2019. PMID: 30663129 Free PMC article. Clinical Trial. No abstract available.

5

Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.

Taher AT, Weber S, Han J, Bruederle A, Porter JB. Taher AT, et al. Among authors: han j. Am J Hematol. 2019 Jan;94(1):E15-E17. doi: 10.1002/ajh.25322. Epub 2018 Nov 15. Am J Hematol. 2019. PMID: 30346059 Free PMC article. No abstract available.

6

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.

Porter JB, Elalfy M, Taher A, Aydinok Y, Lee SH, Sutcharitchan P, El-Ali A, Han J, El-Beshlawy A. Porter JB, et al. Among authors: han j. Eur J Haematol. 2017 Mar;98(3):280-288. doi: 10.1111/ejh.12830. Epub 2017 Jan 13. Eur J Haematol. 2017. PMID: 27859648 Free article. Clinical Trial.

7

Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).

Vichinsky E, El-Beshlawy A, Al Zoebie A, Kamdem A, Koussa S, Chotsampancharoen T, Bruederle A, Gilotti G, Han J, Elalfy M. Vichinsky E, et al. Among authors: han j. Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26507. Epub 2017 Mar 10. Pediatr Blood Cancer. 2017. PMID: 28296163

8

Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11.

Koenig W, Ray KK, Landmesser U, Leiter LA, Schwartz GG, Wright RS, Conde LG, Han J, Raal FJ. Koenig W, et al. Among authors: han j. Am J Prev Cardiol. 2023 May 14;14:100503. doi: 10.1016/j.ajpc.2023.100503. eCollection 2023 Jun. Am J Prev Cardiol. 2023. PMID: 37252442 Free PMC article.

9

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma.

Sternberg CN, Motzer RJ, Hutson TE, Choueiri TK, Kollmannsberger C, Bjarnason GA, Paul Nathan, Porta C, Grünwald V, Dezzani L, Han J, Tannir NM. Sternberg CN, et al. Among authors: han j. Clin Genitourin Cancer. 2019 Dec;17(6):425-435.e4. doi: 10.1016/j.clgc.2019.01.015. Epub 2019 Feb 6. Clin Genitourin Cancer. 2019. PMID: 31601514 Free PMC article. Clinical Trial.

10

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.

Koenig W, Conde LG, Landmesser U, Leiter LA, Ray KK, Schwartz GG, Wright RS, Han J, Raal FJ. Koenig W, et al. Among authors: han j. Cardiovasc Drugs Ther. 2024 Jun;38(3):493-503. doi: 10.1007/s10557-022-07413-0. Epub 2022 Dec 23. Cardiovasc Drugs Ther. 2024. PMID: 36550348 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,920 results

Search Page

Filters